Related references
Note: Only part of the references are listed.Tripartite motif-containing protein 31 confers protection against nonalcoholic steatohepatitis by deactivating mitogen-activated protein kinase kinase kinase 7
Min-Xuan Xu et al.
HEPATOLOGY (2023)
Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta-Activated Kinase 1-c-Jun-N-Terminal Kinase/p38 Signaling
Junyong Wang et al.
HEPATOLOGY (2021)
iRhom2 Promotes Hepatic Steatosis by Activating MAP3K7-Dependent Pathway
Minxuan Xu et al.
HEPATOLOGY (2021)
Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice)
Yanyong Xu et al.
HEPATOLOGY (2021)
Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH
Jinrui Dong et al.
NATURE COMMUNICATIONS (2021)
Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma
Sophie Jacques et al.
SCIENTIFIC REPORTS (2021)
Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes
Eleftherios Michailidis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Origin of Monocytes/Macrophages Contributing to Chronic Inflammation in Chagas Disease: SIRT1 Inhibition of FAK-NF kappa B-Dependent Proliferation and Proinflammatory Activation of Macrophages
Xianxiu Wan et al.
CELLS (2020)
TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation
Dan Liu et al.
CELL METABOLISM (2020)
Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis
Chongshu Jian et al.
CELL METABOLISM (2020)
FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome
Fuming Li et al.
NATURE CELL BIOLOGY (2020)
Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice
Xianhong Du et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Dual-Specificity Phosphatase 9 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through ASK1 Suppression
Ping Ye et al.
HEPATOLOGY (2019)
Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal-Regulating Kinase 1 Pathways
Zhen Huang et al.
HEPATOLOGY (2019)
F-box/WD Repeat-Containing Protein 5 Mediates the Ubiquitination of Apoptosis Signal-Regulating Kinase 1 and Exacerbates Nonalcoholic Steatohepatitis in Mice
Lan Bai et al.
HEPATOLOGY (2019)
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis
Anissa A. Widjaja et al.
GASTROENTEROLOGY (2019)
Regulation of Dual-Specificity Phosphatase (DUSP) Ubiquitination and Protein Stability
Hsueh-Fen Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Up-regulated cathepsin C induces macrophage M1 polarization through FAK-triggered p38 MAPK/NF-κB pathway
Shahid Alam et al.
EXPERIMENTAL CELL RESEARCH (2019)
FAK and Pyk2 activity promote TNF-α and IL-1β-mediated pro-inflammatory gene expression and vascular inflammation
James M. Murphy et al.
SCIENTIFIC REPORTS (2019)
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
Carlos J. Diaz Osterman et al.
ELIFE (2019)
NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment
Ming-Feng Xia et al.
FRONTIERS IN PHARMACOLOGY (2019)
MAP4K Family Kinases and DUSP Family Phosphatases in T-Cell Signaling and Systemic Lupus Erythematosus
Huai-Chia Chuang et al.
CELLS (2019)
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis
Geoff Farrell et al.
HEPATOLOGY (2019)
Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression
Ping Ye et al.
HEPATOLOGY (2019)
DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis
Hsiu-Ping Lin et al.
FASEB JOURNAL (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
Peng Zhang et al.
NATURE MEDICINE (2018)
Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver
Siyuan Wang et al.
HEPATOLOGY (2018)
Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
Marcus Grohmann et al.
CELL (2018)
Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22
F. Arruga et al.
LEUKEMIA (2017)
Pathology of non-alcoholic fatty liver disease
Pierre Bedossa
LIVER INTERNATIONAL (2017)
Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism
Ahmed Lawan et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
Collagen I promotes hepatocellular carcinoma cell proliferation by regulating integrin β1/FAK signaling pathway in nonalcoholic fatty liver
Xinglong Zheng et al.
ONCOTARGET (2017)
DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study
Martin Bjerregard Pedersen et al.
BLOOD (2017)
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk
Stefano Ballestri et al.
ADVANCES IN THERAPY (2017)
Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action
Fernando Bril et al.
DIABETES CARE (2017)
The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment
Cristina Margini et al.
LIVER INTERNATIONAL (2016)
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
Timothy Hardy et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
Giovanni Musso et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance
Sachiko Nishimoto et al.
SCIENCE ADVANCES (2016)
Scaffold Role of DUSP22 in ASK1-MKK7-JNK Signaling Pathway
Anna Ju et al.
PLOS ONE (2016)
Focal adhesion kinase and its role in skeletal muscle
Zachary A. Graham et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2015)
PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease
Jiayun Shen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
Amit G. Singal et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
The role of FAK in tumor metabolism and therapy
Jianliang Zhang et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Hannele Yki-Jarvinen
LANCET DIABETES & ENDOCRINOLOGY (2014)
FAK in cancer: mechanistic findings and clinical applications
Florian J. Sulzmaier et al.
NATURE REVIEWS CANCER (2014)
NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
Geoffrey C. Farrell et al.
GUT AND LIVER (2012)
DUSPs, to MAP kinases and beyond
Ching-Yu Huang et al.
CELL AND BIOSCIENCE (2012)
Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents The TONIC Randomized Controlled Trial
Joel E. Lavine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
FAK is involved in invasion and metastasis of hepatocellular carcinoma
Jing-Song Chen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
JNK Pathway-associated Phosphatase Dephosphorylates Focal Adhesion Kinase and Suppresses Cell Migration
Ju-Pi Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice
Kengo Tomita et al.
HEPATOLOGY (2008)
Focal adhesion kinase (FAK)-related non-kinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner
Qiang Ding et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
In vivo inhibition of focal adhesion kinase causes insulin resistance
Bharti Bisht et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Signaling to NF-κB by Toll-like receptors
Taro Kawai et al.
TRENDS IN MOLECULAR MEDICINE (2007)
DUSP22/LMW-DSP2 regulates estrogen receptor-α-mediated signaling through dephosphorylation of Ser-118
Y. Sekine et al.
ONCOGENE (2007)
Regulation of STAT3-mediated signaling by LMW-DSP2
Y. Sekine et al.
ONCOGENE (2006)
Crystal structure of the FERM domain of focal adhesion kinase
DFJ Ceccarelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Metabolic Obesity: The Paradox Between Visceral and Subcutaneous Fat
Osama Hamdy et al.
CURRENT DIABETES REVIEWS (2006)
Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis
A Laurent et al.
HEPATOLOGY (2004)
FAK regulates biological processes important for the pathogenesis of cancer
V Gabarra-Niecko et al.
CANCER AND METASTASIS REVIEWS (2003)
The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway
AJ Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Focal adhesion kinase (FAK) regulates insulin-stimulated glycogen synthesis in hepatocytes
DS Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR)
A Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activation of the Jnk signaling pathway by a dual-specificity phosphatase, JSP-1
Y Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
